A New Zealand bladder cancer detection firm is opening its U.S. office at the biotechnology incubator Hershey Center for Applied Research, in a move that will add 100 jobs over three years.
Pacific Edge Diagnostics will market its bladder cancer detection test, Cx Bladder, to urologists at the end of the year, according to a statement from the company. Its 11,348-square-foot offices will be located by the technology suites — a project funded by the economic development administration of the state’s commerce department to provide subsidized lab and office suites for technology companies that is set to open in August.
The five-year-old center has a strategic partnership with Penn State University and the Penn State Milton S. Hershey Medical Center.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
HCAR currently has $2 million in capital available for companies looking to locate to its Knowledge Community incubator, according to a statement from the center.
Pacific Edge Diagnostics is the 12th company at the facility and the third from the Australia and New Zealand region.
